Related by context. All words. (Click for frequent words.) 81 coronary calcium 78 coronary artery calcification 74 subclinical atherosclerosis 72 Coronary artery calcium 70 electron beam computed tomography 69 calcified plaque 68 carotid IMT 67 coronary calcification 66 hsCRP 65 Framingham Risk Score 65 elevated CRP 65 subclinical hyperthyroidism 65 serum PSA 64 MetS 64 carotid intima media 64 cTnT levels 64 troponin T 64 albuminuria 63 coronary artery disease 63 gallstone disease 63 microalbuminuria 63 advanced neoplasia 62 prostate cancer CaP 62 PSA velocity 62 BMI z 62 C reactive protein 62 carotid plaque 62 nonfasting triglyceride levels 62 preoperative PSA 62 EBCT 62 fasting insulin 62 subclinical hypothyroidism 62 colorectal neoplasia 62 hs CRP 62 NAFLD 62 elevated homocysteine 62 advanced adenoma 62 coronary angiography 62 LV dysfunction 62 polyp recurrence 62 intima media thickness 61 Lp PLA2 61 cTnT 61 carotid atherosclerosis 61 carotid ultrasound 61 carotid stenosis 61 coronary stenosis 61 cystatin C 61 impaired fasting glucose 61 PCa 61 colorectal adenoma 61 white matter hyperintensities 61 comorbidity 61 adenoma recurrence 61 stratifying patients 61 CHADS2 61 statin therapy 60 adenoma 60 plasma homocysteine 60 hydroxyvitamin D levels 60 atherosclerotic disease 60 hemoglobin A1c levels 60 catheter angiography 60 systolic dysfunction 60 Prostate Specific Antigen PSA 60 postoperative AF 60 cognitively normal 60 Coronary calcium 60 obstructive coronary artery 60 fasting glucose levels 60 serum selenium 60 urate levels 60 APOE e4 60 pretest probability 60 colorectal adenomas 60 advanced adenomas 60 obstructive CAD 60 coronary disease 60 atypical hyperplasia 60 carotid bruit 60 Coronary artery calcification 60 silent myocardial ischemia 60 transferrin saturation 60 estimated glomerular filtration 60 PSADT 60 tHcy 60 highest tertile 59 lowest tertile 59 specific antigen PSA 59 FDG PET scans 59 serum uric acid 59 atypia 59 microbleeds 59 D dimer 59 angiographically 59 Prehypertension 59 lipid lowering therapy 59 Framingham Offspring Study 59 clinically insignificant 59 multivessel disease 59 glycated hemoglobin levels 59 platelet reactivity 59 dose ionizing radiation 59 Skin sterol 59 adiponectin levels 59 telomere lengths 59 macrovascular disease 59 arterial stiffness 59 HOMA IR 59 left ventricular dysfunction 59 cirrhotic patients 59 abdominal adiposity 59 nonfasting triglycerides 59 thickness IMT 59 body fatness 59 antigen PSA 59 comorbidities 58 ischemic stroke 58 Reynolds Risk Score 58 proteinuria 58 pCR 58 BRCA mutation 58 subclinical 58 MMSE scores 58 left ventricular hypertrophy 58 carotid artery thickness 58 APOE genotype 58 cardiovascular mortality 58 screening colonoscopy 58 cardioembolic stroke 58 elevated triglyceride levels 58 rs# [002] 58 #.#ng/ml 58 myocardial perfusion 58 thyroid nodules 58 homocysteine levels 58 albumin excretion rate 58 mammographic density 58 urate 58 prostate biopsy 58 thickness CIMT 58 biochemical recurrence 58 perimenopausal women 58 albumin excretion 58 silent ischemia 58 carotid artery ultrasound 58 serum ferritin 58 invasive coronary angiography 58 intact parathyroid hormone 58 myocardial infarction MI 58 obstructive coronary 58 distal colon cancer 58 coronary blockages 58 Lp PLA 2 58 preoperatively 58 venous thrombosis 58 nondiabetic 58 thyroglobulin 58 proliferative diabetic retinopathy 58 elevated LDL cholesterol 58 microvascular disease 58 arterial calcification 57 diabetes mellitus DM 57 serum parathyroid hormone 57 coronary CT angiography 57 nondiabetic patients 57 postmenopausal breast cancer 57 eGFR 57 artery stenosis 57 coronary CTA 57 thromboembolic 57 atherothrombotic disease 57 colorectal polyps 57 HER2 expression 57 genetic variants associated 57 HbA 1c 57 Subgroup analyzes 57 echocardiographic 57 BRCA1 mutations 57 BRCA2 mutations 57 ankle brachial index 57 elevated triglycerides 57 rheumatoid factor 57 cardiac troponin T 57 urine NGAL 57 electron beam tomography 57 BRCA mutations 57 abnormal lipid 57 NSTE ACS 57 bowel polyps 57 contralateral breast cancer 57 β blockers 57 ductal cancer 57 cardiovascular disease 57 MMSE score 57 adenomatous polyps 57 daytime dozing 57 hip BMD 57 asymptomatic carotid stenosis 57 undergoing coronary angiography 57 lymph node metastases 57 FeNO 57 transient elastography 57 urinary albumin 57 conventional angiography 57 C Reactive Protein 57 alanine aminotransferase ALT 57 lipoprotein 57 T1DM 57 glomerular filtration 57 soluble CD# ligand 57 atherothrombosis 57 asymptomatic 57 knee OA 57 ABCB1 57 atherogenic dyslipidemia 57 recurrent atrial fibrillation 57 VADT 57 serum creatinine levels 57 hemoglobin A1C 56 APOE4 56 TT genotype 56 amnestic MCI 56 visceral adiposity 56 NYHA functional class 56 CT angiography 56 myocardial viability 56 HbA1c levels 56 elevated depressive symptoms 56 upper gastrointestinal bleeding 56 vertebral fracture 56 postoperative delirium 56 chronic periodontitis 56 carotid artery intima media 56 hydroxyvitamin D 56 endometrial carcinoma 56 myocardial ischemia 56 thiazide diuretics 56 epithelial ovarian cancer 56 CK MB 56 nondiabetics 56 oxidized phospholipids 56 risk stratification 56 undergoing radical prostatectomy 56 exhaled nitric oxide 56 inflammatory biomarkers 56 microvascular complications 56 intensive statin therapy 56 IBDQ 56 serum calcium 56 computed tomography scans 56 nonfatal MI 56 coronary atherosclerosis 56 thyrotropin levels 56 testosterone supplementation 56 genomewide 56 Hb A1C 56 LDL particle 56 serum testosterone 56 fasting glucose 56 elevated serum creatinine 56 chest radiographs 56 prehypertension 56 glycated hemoglobin HbA1c 56 underwent coronary angiography 56 APACHE II 56 serum lipid levels 56 Multiple logistic regression 56 skin sterol 56 paricalcitol 56 cardiac computed tomography 56 cerebral infarction 56 CT coronary angiography 56 serum estradiol 56 central adiposity 56 depressive symptomatology 56 CVD mortality 56 BRCA2 mutation carriers 56 femoral neck BMD 56 RBP4 56 NIHSS 56 postoperative mortality 56 non fasting triglycerides 56 postoperative atrial fibrillation 56 QRISK 56 intraobserver 56 serum urate levels 56 histopathologic 56 waist circumference 56 DXA 56 extracolonic findings 56 CHADS 2 56 familial hypercholesterolemia 56 renal dysfunction 56 IPSS 56 Multivariate analysis 56 prognostic indicators 56 malignant nodules 56 androgen deficiency 56 digital rectal examination 56 CIN3 56 perioperative mortality 56 recurrent VTE 56 serum thyroglobulin 56 pelvic lymphadenectomy 56 creatinine levels 56 atherosclerotic lesions 56 aminotransferase ALT 56 periodontitis 56 postoperative pulmonary 56 bilateral oophorectomy 56 serum folate 56 diastolic function 56 conventional coronary angiography 56 multivariate analyzes 56 serum cholesterol 56 abdominal obesity 56 benign lesions 56 lymph node metastasis 56 helical CT 56 severe periodontitis 56 lobular breast cancer 56 metabolic syndrome MetS 56 T2DM 56 cardiac dysfunction 56 CT angiograms 56 spirometric 56 poorer prognosis 56 rs# [001] 56 etiologic 55 noncalcified 55 prenatal testosterone 55 TGFBR1 * 6A 55 logistic regression model 55 stable angina 55 prognostic variables 55 liver biopsy 55 genetic polymorphisms 55 biopsy Gleason 55 inflammatory markers 55 hypertensives 55 MGUS 55 osteopenic 55 selenium supplementation 55 myocardial infarction 55 stratify patients 55 nonvertebral fractures 55 multivariable analysis 55 ventricular mass 55 lobular cancer 55 carotid artery blockage 55 contrast induced nephropathy 55 non aspirin NSAIDs 55 chlamydial infection 55 HNSCC 55 PSA nadir 55 Endothelial function 55 prostate specific antigen 55 colorectal neoplasms 55 specific antigen 55 cognitive impairment 55 urine cytology 55 anti JCV antibodies 55 autonomic dysfunction 55 Logistic regression analysis 55 Coronary Artery Calcium 55 adrenalectomy 55 coronary heart 55 lymph node involvement 55 polyp detection 55 calcified plaques 55 artery blockages 55 neurocognitive function 55 axillary lymph nodes 55 airflow obstruction 55 postoperative complication 55 CC genotype 55 mIU L 55 fetuin 55 atherosclerosis 55 nonfasting 55 beta blocker therapy 55 hepatic steatosis 55 artery calcification 55 nodal metastases 55 FDG PET 55 2D 4D ratio 55 lobular carcinoma 55 NSTEMI 55 PSA kinetics 55 β amyloid 55 renal artery stenosis 55 basal cell nevus syndrome 55 cardiorespiratory fitness 55 depressive symptoms 55 BRCA2 mutation 55 antihypertensive medications 55 hemoglobin A1c HbA1c 55 systolic hypertension 55 coronary artery stenosis 55 cardiac troponin 55 CaP 55 ADAS Cog 55 modifiable risk 55 postmenopausal hormone 55 Liver biopsy 55 nodal metastasis 55 lactate dehydrogenase LDH 55 Epworth Sleepiness Scale 55 salivary cortisol 55 prognostic significance 55 oncologic outcomes 55 amyloid deposition 55 atheroma 55 inotropic 55 ejection fractions 55 adrenal function 55 ASCUS 55 undergone radical prostatectomy 55 tissue oxygenation 55 thromboembolic events 55 endometrial hyperplasia 55 immunohistochemical 55 ductal breast cancer 55 MSMB 55 androgen deprivation 55 #F FDG PET 55 Framingham Offspring 55 esophageal squamous cell carcinoma 55 invasive angiography 55 nonmelanoma skin cancers 55 pulmonary angiography 55 nonalcoholic steatohepatitis NASH 55 NIH CPSI 55 serum folate concentrations 55 index BMI 55 N telopeptide 55 B7 H3 55 ovarian hormones 55 rs# [003] 55 benign breast 55 CIN2 + 55 glycosylated hemoglobin 55 computed tomography CT scan 55 nonobstructive CAD 55 LQTS 55 MSCT 55 unstable angina 55 serum vitamin D 55 liver histology 55 hematuria 55 folate intake 54 depressive symptom 54 intravascular ultrasonography 54 A1c levels 54 microsatellite instability 54 cytologic 54 c reactive protein 54 Kaplan Meier analysis 54 F2 isoprostanes 54 noncarriers 54 atypical ductal hyperplasia 54 dietary calcium intake 54 nonischemic 54 CHADS 54 glycemia 54 angiotensin converting enzyme 54 abnormal lipid levels 54 glycosylated hemoglobin HbA1c 54 serum CRP 54 breast cancer metastasis 54 malignant lesions 54 highest quintile 54 prognostic factors 54 subclinical disease 54 HRCT 54 HbA1C 54 autoantibodies 54 FFR measurements 54 gestational diabetes mellitus 54 metabolic syndrome 54 nonmelanoma skin cancer 54 SLNB 54 T2D 54 carotid plaques 54 dose atorvastatin 54 folate deficiency 54 CT colonography 54 Logistic regression 54 Proteinuria 54 psychosocial variables 54 angiotensin receptor blockers ARBs 54 premenopausal 54 nondepressed 54 tumor recurrence 54 CP CPPS 54 Crohn Disease Activity 54 remnant lipoproteins 54 oophorectomy 54 hematopoietic cancers 54 residual platelet reactivity 54 microvascular dysfunction 54 nonvertebral fracture 54 univariate analyzes 54 perioperative morbidity 54 antihypertensive therapy 54 PCA3 54 multivariate Cox 54 mammographically 54 waist circumference WC 54 prostate cancer PCa 54 scintigraphic 54 deCODE BreastCancer TM 54 DAS# [002] 54 stress echocardiography 54 aminotransferases 54 oropharyngeal cancer 54 interobserver 54 arterial thickening 54 Prostate Specific Antigen 54 lipid lowering medications 54 COR Analyzer 54 psychiatric comorbidities 54 APOL1 54 hyperintense lesions 54 cTnI 54 premenopausal breast cancer 54 calcium supplementation 54 left ventricular systolic 54 shorter telomere length 54 adenomas 54 Insulin sensitivity 54 postmenopausal hormones 54 contralateral breast 54 clusterin 54 cerebral microbleeds 54 logistic regression analyzes 54 histological subtype 54 troponins 54 antioxidant supplementation 54 rate variability HRV 54 myocardial infarctions 54 CT angiogram 54 preoperative chemotherapy 54 coronary arteriography 54 endometrial thickness 54 hsCRP levels 54 transaminase levels 54 EUS FNA 54 perioperative complications 54 spiral computed tomography 54 serum PTH 54 apnea hypopnea index 54 pathologic fractures 54 hyperglycaemia 54 cranial irradiation 54 prostate specific 54 SGRQ 54 micrometastasis 54 serum testosterone levels 54 Glasgow Coma Scale 54 PHQ 9 54 APOE gene 54 Subgroup analysis 54 LDL HDL 54 parkinsonism 54 colon polyps 54 fasting triglycerides 54 NMIBC 54 Stop Hypertension DASH diet 54 telomere length 54 thyroid stimulating hormone 54 perfusion defects 54 Leitzmann 54 insulin resistance 54 PGDH 54 NT proBNP 54 NNRTI resistance 54 hydroxychloroquine 54 breast cancer recurrence 54 osteoporotic fracture 54 coronary arterial 54 habitual snoring 54 infarct size 54 polycystic ovary syndrome PCOS 54 aortic stiffness 54 CMV infection 54 HRQL 54 cardiac magnetic resonance 54 elevated creatinine 54 precursor lesions 54 colonoscopic 54 myeloperoxidase 54 BRCA mutation carriers 54 undergoing CABG 54 lipoprotein levels 54 paroxysmal AF 54 comorbid conditions 54 NGAL 54 endothelial dysfunction 54 LVEF 54 leiomyomas 54 QTc 54 DEXA 54 Index CDAI 54 DEXA scans 54 hemoglobin A1c 54 reflux disease 54 Ejection Fraction 54 angiograms 54 endarterectomy 54 cortisol concentrations 54 HER2 amplification 54 F FDG PET 54 arterial stiffening 54 colorectal cancer CRC 54 Recurrence Score 54 elevated ALT 54 acute aortic dissection 54 thromboembolic complications 54 mL/min/#.# m 2 54 steatosis 54 APOE e4 gene 54 HRQoL 53 fasting plasma 53 lipid profiles 53 normotensive 53 gene APOE 53 carotid endarterectomy 53 metabolic disturbances 53 beta carotene supplementation 53 FDG PET imaging 53 Functional magnetic resonance 53 colonic polyps 53 lipid levels 53 extracapsular extension 53 glomerular filtration rate 53 procalcitonin 53 hypercalciuria 53 gingival bleeding 53 HRQOL 53 Magnetic resonance imaging 53 Screening Trial DMIST 53 serum creatinine 53 Digital Mammographic Imaging 53 thrombolytic therapy 53 plasma folate 53 PON1 activity 53 cardio respiratory fitness 53 arterial plaque 53 distensibility 53 LTBI 53 BMD measurements 53 atheroma volume 53 periprocedural 53 fasting plasma glucose 53 antiphospholipid antibodies 53 HDL2 53 exhaled NO 53 gene variants 53 prognostic 53 adiponectin 53 HGPIN 53 breast carcinoma 53 isolated systolic hypertension 53 oral anticoagulation 53 carotid artery stenosis 53 seminal vesicle invasion 53 serum potassium 53 estrogen receptor ER 53 hypoxemia 53 perfusion abnormalities 53 dose clopidogrel 53 circulating EPCs 53 SRBD 53 acetabular dysplasia 53 lung nodule 53 multivariable adjusted 53 intima media thickness IMT 53 node metastases 53 leukocyte count 53 diastolic blood pressures 53 penetrance 53 slow metabolizers 53 metabolic abnormalities 53 triacylglycerol concentrations 53 Univariate analysis 53 autistic traits 53 ischemic lesions 53 nonpregnant women 53 T2 lesions 53 incomplete revascularization 53 noncancer 53 cardiovascular morbidity 53 estrogen receptor negative 53 biochemical relapse 53 DCCT 53 estimated GFR 53 serum phosphate 53 PCA3 scores 53 atherosclerotic 53 retrospective cohort 53 BRCA1 mutation carriers 53 neurological abnormalities 53 GBA mutations 53 primary ovarian insufficiency 53 brain lesions 53 coronary angiogram 53 logistic regression models 53 dietary folate 53 chest radiography 53 heterozygotes 53 diastolic dysfunction 53 liver biopsies 53 fructose diet 53 bone mineral 53 sUA 53 systolic pressure 53 OGTT 53 serum triglyceride 53 asymptomatic PAD 53 Genetic variants 53 giant cell arteritis 53 recurrent miscarriage 53 warfarin therapy 53 cardiovascular disease CVD 53 narcolepsy cataplexy 53 pre eclamptic 53 peptide BNP 53 pericardial fat 53 APOE ε4 53 logistic regression analysis 53 CHD 53 hippocampal volume 53 periprocedural MI 53 diastolic pressures 53 KIF6 carriers 53 lipid lowering drugs 53 GSTT1 53 prescribe statins 53 multivariate logistic regression 53 axillary node 53 thrombotic events 53 ERCC1 53 varicocele 53 cervical lesions 53 HSCT 53 BMI percentile 53 colorectal polyp 53 elevated fasting glucose 53 left ventricular LV 53 System IPSS 53 refractory ischemia 53 airway responsiveness 53 folate supplementation 53 2 diabetes T2D 53 lipid abnormalities 53 noncardiac 53 sudden cardiac death 53 serum BDNF 53 myocardial uptake 53 arterial elasticity 53 malignant polyps 53 hormone therapy estrogen 53 adiponectin concentrations 53 UKPDS 53 aminotransferase levels 53 Waist circumference 53 noncardiac surgery 53 #OHD levels 53 morphologic 53 periodontal disease 53 hyperhomocysteinemia 53 ratio WHR 53 fibrosis 53 pre cancerous polyps 53 operable breast cancer 53 core needle biopsies 53 tertiles 53 magnesium intake 53 8 OHdG 53 deep venous thrombosis 53 KIF6 gene variant 53 #mmHg [001] 53 #.#mmol L [002] 53 coronary revascularization 53 grade cervical intraepithelial 53 antidiabetic medication 53 BMI waist circumference 53 serum cortisol 53 amino acid homocysteine 53 dose Iluvien 53 biochemical marker 53 shorter telomeres 53 central corneal thickness 53 allostatic load 53 International Prognostic Scoring 53 impaired glucose metabolism 53 Observational studies 53 poor metabolizers 53 Hurthle cell 53 Charlson Comorbidity Index 53 salivary cotinine 53 serum prostate 53 Abdominal fat 53 renal cell carcinomas 53 Ovary removal 53 urine albumin 53 apolipoprotein A1 53 USPSTF recommends 53 CNS LS 53 homocysteine 53 intravascular ultrasound 53 electrocardiography 53 elevated LDL 53 plasma lipid 53 platelet activation 53 Prostate specific antigen 53 breast lesions 53 thiopurine 53 cerebral perfusion 53 density lipoprotein cholesterol 53 venous thromboembolism 53 TP# mutations 53 MDCT angiography 53 sleep disordered breathing 53 Coronary angiography 53 State Examination MMSE 53 polycystic ovary syndrome 53 eosinophil count 53 radical nephrectomy 53 colonoscopy screenings 53 HbA1C levels 53 posttransplant 53 urinary calcium 53 serum homocysteine 53 systemic inflammation 53 SLN biopsy 53 Getzenberg 53 familial pancreatic cancer 53 serum concentrations 53 colon rectal 52 baseline HbA1c 52 cryptogenic stroke 52 arteriography 52 oral glucose tolerance 52 DAS# scores 52 POAG 52 Ascherio 52 definite stent thrombosis 52 genetic variant 52 patients undergoing CABG 52 stratifying 52 adenotonsillectomy 52 R0 resection 52 urolithiasis 52 HIV HCV coinfected 52 S#A# [002] 52 dyssynchrony 52 electrocardiographic 52 prostate adenocarcinoma 52 QTc interval 52 LV hypertrophy 52 stenoses 52 serum phosphorous 52 apolipoprotein B 52 Multivariate analyzes 52 postoperative complications 52 OPCAB 52 PD2i R 52 serum glucose 52 CARDIA study 52 primary aldosteronism 52 Glomerular filtration rate 52 uncontrolled hypertension 52 Charlson comorbidity index 52 microvessel density 52 Garzotto 52 Oncotype DX Recurrence Score 52 RBP4 levels 52 revascularization 52 DLQI 52 homocysteine concentrations 52 glucose intolerance 52 histologically proven 52 SUVmax 52 plain radiographs 52 SE alleles 52 PSQI 52 renal tumors 52 prostate carcinoma 52 extraversion 52 grade gliomas 52 cotinine levels 52 urothelial carcinoma 52 neoplasia PIN 52 endometrial cancers 52 nondrinkers 52 systolic function 52 chemoembolization 52 nephron sparing surgery 52 neurocognitive impairment 52 intracranial atherosclerosis 52 HG PIN 52 Ki# 52 Elevated cholesterol 52 sCJD 52 cholesterol triglycerides 52 T1a 52 nonobstructive 52 transcranial Doppler 52 rebleeding 52 elevated uric acid 52 ventricular tachyarrhythmia 52 testicular germ cell 52 postmenopausal women 52 lymph node biopsies 52 abnormal glucose tolerance 52 carotid artery narrowing 52 APOE allele 52 rCBF 52 epicardial adipose tissue 52 multivariate analysis 52 clinically meaningful improvement 52 serum bilirubin 52 metabolic parameters 52 angina chest 52 serum leptin 52 lowering homocysteine 52 neoplasia 52 fasting serum 52 de ath 52 serum GGT 52 plasma homocysteine levels 52 adiposity 52 psychiatric morbidity 52 apolipoprotein E 52 flexible sigmoidoscopy 52 hypertensive patients 52 macrovascular 52 PSA screening 52 atherothrombotic 52 mineral density 52 bladder carcinoma 52 SYNTAX 52 HDL cholesterol triglycerides 52 CLBP 52 dyslipidaemia 52 vitamin D insufficiency 52 prehypertensive 52 arterial inflammation 52 BI RADS 52 clinically localized prostate 52 GSTP1 52 BRCA2 carriers 52 histologically confirmed 52 Neuroticism 52 chronic pancreatitis 52 nonfatal myocardial infarction 52 bioavailable testosterone 52 thyrotropin 52 density lipoprotein cholesterol HDL 52 DXA scan 52 intracranial stenosis 52 detecting colorectal cancer 52 Montgomery Åsberg Depression 52 computed tomography angiography 52 ejection fraction 52 univariate analysis 52 thrombotic complications 52 osteopontin 52 HbA 1c levels 52 thromboembolism 52 apolipoproteins 52 Premenopausal women 52 nonalcoholic fatty liver 52 gene variant 52 contrast echocardiography 52 International Prostate Symptom 52 immunohistochemical analysis 52 LUTS 52 premenopausal women 52 serous ovarian cancer 52 TCF#L# 52 microalbumin test 52 histologic 52 serum IgE 52 varices 52 dysglycemia 52 EGFR mutations 52 impaired glucose tolerance 52 prognostic factor 52 Thrombolysis 52 uric acid levels 52 airway hyperresponsiveness 52 diagnose Alzheimer disease 52 serum lipids 52 recurrent UTI 52 precancer